Jump to page content Accessibility
News, views and contacts from the global Pharmaceutical industry
Login to pharmaceutical-technology.com Log in or Register
  • Home
  • Products & Services
  • Company A - Z
  • Projects
  • Features
  • Videos
  • White Papers
  • News
  • Events
  • Advertise With Us
Industry Projects | Projects by Region | Projects by Category | Archived Projects | Project Gallery
 

Novavax Vaccine Plant, United States of America



The VLP approach uses non-pathogenic insect cell cultures in production.


  • The Novavax facility is a pilot-scale facility but will soon be able to...

  • VLP technology is expected to revolutionise vaccine production.

  • A VLP plant can be set up for about a quarter of the cost of an egg-based...

  • A lot of equipment used in production is disposable, meaning much lower costs...

  • VLP vaccines need much lower doses than traditional vaccines to be effective.

  • The VLP approach uses non-pathogenic insect cell cultures in production.

Back to Project Details



Related Projects

Bipha Human Serum Albumin Plant
The Chitose project was the world's first human serum albumin plant,...

ScinoPharm Bulk Pharmaceutical Plant
The ScinoPharm bulk pharmaceutical plant is located at the Tainan...

Lonza Niacinamide Production Facility
Lonza Fine Chemicals and Specialties, a major producer based in...

Roche Vitamin Plant
Roche's latest vitamin plant is located in Taishan (Shanghai) which is in...

DSM Premix Vitamin Plant
The vitamin premix plant at El Salto in Jalisco, Mexico (near...

See all projects


Follow Us:
Twitter Twitter   
Contact us
Advertise with us
Terms and conditions
Privacy
Links
Newsletter sign up
Online magazine sign up

pharmaceutical-technology.com is a product of Net Resources International. Copyright 2011 Net Resources International, a trading division of SPG Media Limited.